Isofol Medical
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
ISOFOL | ST
Overview
Corporate Details
- ISIN(s):
- SE0009581051
- LEI:
- 549300MCXYAHG7VBHX75
- Country:
- Sweden
- Address:
- C/O Biotech Center, Arvid Wallgrens, 413 46 Göteborg
- Website:
- https://isofolmedical.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Isofol Medical AB is a research-based biotechnology company focused on improving the prognosis for patients with severe forms of cancer. The company develops its primary drug candidate, arfolitixorin, with the aim of increasing the efficacy of first-line standard chemotherapy treatments for various solid tumors. A key area of development is colorectal cancer, where the company is conducting a Phase Ib/II clinical study to optimize the drug candidate's dosing regimen and therapeutic effect.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-12 08:00 |
Quarterly Report
|
Swedish | 11.9 MB | ||
| 2025-11-12 08:00 |
Quarterly Report
|
English | 12.0 MB | ||
| 2025-11-04 09:45 |
Board/Management Information
Isofol appoints nomination committee ahead of the Annual General Meeting 2026
|
English | 454.1 KB | ||
| 2025-11-04 09:45 |
Board/Management Information
Isofol har utsett valberedning inför årsstämman 2026
|
Swedish | 377.2 KB | ||
| 2025-09-23 10:45 |
Major Shareholding Notification
|
Swedish | 10.5 KB | ||
| 2025-08-26 08:00 |
Interim Report
|
Swedish | 7.2 MB | ||
| 2025-08-26 08:00 |
Interim Report
|
English | 2.6 MB | ||
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Nytt antal aktier och röster i Isofol
|
Swedish | 60.6 KB | ||
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
New number of shares and votes in Isofol
|
English | 61.3 KB | ||
| 2025-07-04 18:00 |
Share Issue/Capital Change
Isofol's rights issue fully subscribed – exercises overallotment for Japanese p…
|
English | 128.5 KB | ||
| 2025-07-04 18:00 |
Share Issue/Capital Change
Isofols företrädesemission övertecknad – utnyttjar övertilldelning till japansk…
|
Swedish | 127.3 KB | ||
| 2025-06-17 08:40 |
Prospectus
Isofol offentliggör prospekt i samband med bolagets företrädesemission
|
Swedish | 98.7 KB | ||
| 2025-06-17 08:40 |
Prospectus
Isofol publishes prospectus in connection with the company’s rights issue
|
English | 119.6 KB | ||
| 2025-06-11 14:00 |
Post-Annual General Meeting Information
Bulletin from extraordinary general meeting in Isofol Medical AB (publ) held on…
|
English | 94.5 KB | ||
| 2025-06-11 14:00 |
Post-Annual General Meeting Information
Kommuniké från extra bolagsstämma i Isofol Medical AB (publ) den 11 juni 2025
|
Swedish | 74.5 KB |
Automate Your Workflow. Get a real-time feed of all Isofol Medical filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Isofol Medical
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Isofol Medical via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-11 | Magnus Hurst | Other | Buy | 35,000 | 24,150.00 SEK |
| 2022-09-12 | AB Windar | Other | Buy | 500,000 | 305,000.00 SEK |
| 2021-12-09 | Tony Gustavsson | Other | Sell | 58,767 | 858.00 SEK |
| 2021-12-09 | Tony Gustavsson | Other | Sell | 58,767 | 152.79 SEK |
| 2021-06-14 | HealthCom GmbH | Other | Buy | 233,336 | 1,493,350.40 SEK |
| 2021-06-10 | Gustaf Albèrt | Other | Other | 15,153 | 96,979.20 SEK |
| 2020-11-23 | Tony Gustavsson | Other | Buy | 58,767 | 43,487.58 SEK |
| 2020-11-23 | Tony Gustavsson | Other | Buy | 58,767 | 29,971.17 SEK |
| 2020-11-16 | Sven Eriksson | Other | Sell | 58,767 | 43,487.58 SEK |
| 2020-11-16 | Sven Eriksson | Other | Sell | 58,767 | 29,971.17 SEK |
Peer Companies
